Bing Wu

机构：Zhejiang Chinese Medical University · ORCID：0000-0002-6690-4884

发表论文 94 篇 · 总被引 1418 次 · h-index 21

代表论文

• Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial (2023 · Annals of Oncology · 被引 82)
• Paeoniflorin attenuates cuproptosis and ameliorates left ventricular remodeling after AMI in hypobaric hypoxia environments (2024 · Journal of Natural Medicines · 被引 26)
• Total neoadjuvant treatment with long-course radiotherapy versus concurrent chemoradiotherapy in local advanced rectal cancer with high risk factors (TNTCRT): A multicenter, randomized, open-label, phase 3 trial. (2024 · Journal of Clinical Oncology · 被引 18)
• Predicting Rectal Cancer Response to Total Neoadjuvant Treatment Using an Artificial Intelligence Model Based on Magnetic Resonance Imaging and Clinical Data (2023 · Technology in Cancer Research & Treatment · 被引 9)
• Radiological biomarkers reflecting visceral fat distribution help distinguish inflammatory bowel disease subtypes: a multicenter cross-sectional study (2024 · Insights into Imaging · 被引 8)
• Effectiveness of simultaneous multislice accelerated readout-segmented echo planar imaging for the assessment of rectal cancer (2022 · European Journal of Radiology · 被引 8)